Wohl D, et al. Patient-reported outcomes among HIV-1-infected adults randomized to B/F/TAF versus DTG/ABC/3TC in two Phase 3 controlled clinical trials over 48 weeks. AIDS 2018.
Webcast 'Gordelroospreventie in medische risicogroepen – van indicatie tot vaccinatie'
jan 2026 | IBD, Multipele Sclerose, Psoriasis, RA, SLE, Spondyloartritis, Vaccinatie, Virale infecties